CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy

Author:

Yang Fengchang,Zhang Jiayi,Zhou Liu,Xia Wei,Zhang Rui,Wei Haifeng,Feng Jinxue,Zhao Xingyu,Jian Junming,Gao Xin,Yuan ShuanghuORCID

Funder

National Natural Science Foundation of China

Shandong Key Research and Development Plan

Guangdong Provincial Key Research and Development Program

Chinese Academy of Sciences-Iranian Vice Presidency for Science and Technology Silk Road Science Fund

Science and Technology Plan Projects of Jiangsu

Outstanding Youth Natural Science Foundation of Shandong Province

Jinan Clinical Medicine Science and Technology Innovation Plan

National Key Research and Development Program of China

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference49 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA Cancer J Clin 69(1):7–34

2. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics. CA Cancer J Clin 58(2):71–96

3. Cancer Research UK. Types of lung cancer. www.cancerresearchuk.org/about-cancer/lung-cancer/stages-typesgrades/types. Accessed 25 Sep 2019

4. American cancer society. Survival rates for non-small cell lung cancer. www.cancer.org. Accessed 21 Mar 2020

5. Eberhardt WE, De Ruysscher D, Weder W et al (2015) 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 26(8):1573–1588

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3